(July 20 13:46) Tech.einnews.com
CHINESE biotechnology company WuXi Biologics has announced plans to invest S$2 billion over the next 10 years to expand its research and development efforts and large-scale drug manufacturing capacity and capabilities in Singapore.
You can find the original article
here